BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28255019)

  • 21. Unrelated umbilical cord stem cell transplantation in an eleven-month-old male infant with Wiskott-Aldrich syndrome.
    Chen CY; Chiou YH; Su HW; Chang YH
    Kaohsiung J Med Sci; 2018 Feb; 34(2):122-123. PubMed ID: 29413229
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated donor BMT for Wiskott-Aldrich syndrome.
    Lenarsky C; Weinberg K; Kohn DB; Parkman R
    Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umbilical cord blood infusion in a patient for correction of Wiskott-Aldrich syndrome.
    Kernan NA; Schroeder ML; Ciavarella D; Preti RA; Rubinstein P; O'Reilly RJ
    Blood Cells; 1994; 20(2-3):245-8. PubMed ID: 7749101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report.
    Pury S; López Orozco M; Pichichero G; Sasia LV; Morell D; Álvarez MS; Basquiera AL; Mas ME; Salvucci K
    Arch Argent Pediatr; 2024 Feb; 122(1):e202310061. PubMed ID: 37471507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
    Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.
    Bizzetto R; Bonfim C; Rocha V; Socié G; Locatelli F; Chan K; Ramirez O; Stein J; Nabhan S; Miranda E; Passweg J; de Souza CA; Gluckman E;
    Haematologica; 2011 Jan; 96(1):134-41. PubMed ID: 21071499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
    Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis.
    Albert MH; Slatter MA; Gennery AR; Güngör T; Bakunina K; Markovitch B; Hazelaar S; Sirait T; Courteille V; Aiuti A; Aleinikova OV; Balashov D; Bernardo ME; Bodova I; Bruno B; Cavazzana M; Chiesa R; Fischer A; Hauck F; Ifversen M; Kałwak K; Klein C; Kulagin A; Kupesiz A; Kuskonmaz B; Lindemans CA; Locatelli F; Lum SH; Maschan A; Meisel R; Moshous D; Porta F; Sauer MG; Sedlacek P; Schulz A; Suarez F; Vallée TC; Winiarski JH; Zecca M; Neven B; Veys P; Lankester AC
    Blood; 2022 Mar; 139(13):2066-2079. PubMed ID: 35100336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.
    Kato K; Yoshimi A; Ito E; Oki K; Hara J; Nagatoshi Y; Kikuchi A; Kobayashi R; Nagamura-Inoue T; Kai S; Azuma H; Takanashi M; Isoyama K; Kato S;
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1814-21. PubMed ID: 21664471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
    Knutsen AP; Wall DA
    J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott-Aldrich syndrome.
    Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schumm M; Handgretinger R
    Bone Marrow Transplant; 2000 Jul; 26(2):235-7. PubMed ID: 10918439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation.
    Pai SY; DeMartiis D; Forino C; Cavagnini S; Lanfranchi A; Giliani S; Moratto D; Mazza C; Porta F; Imberti L; Notarangelo LD; Mazzolari E
    Bone Marrow Transplant; 2006 Nov; 38(10):671-9. PubMed ID: 17013426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis.
    Furtado-Silva JM; Paviglianiti A; Ruggeri A; Boelens JJ; Veys P; Ahmari AA; Zecca M; Locatelli F; Michel G; Volt F; Kenzey C; Sedlacek P; Rao K; Lankester A; Gluckman E; Rocha V;
    Br J Haematol; 2019 Feb; 184(3):397-404. PubMed ID: 30460979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
    Ngwube A; Hanson IC; Orange J; Rider NL; Seeborg F; Shearer W; Noroski L; Nicholas S; Forbes L; Leung K; Sasa G; Naik S; Hegde M; Omer B; Ahmed N; Allen C; Gottschalk S; Wu MF; Liu H; Brenner M; Heslop H; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):537-541. PubMed ID: 29196075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.
    Yue Y; Shi X; Song Z; Qin J; Li J; Feng S; Liu R
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27092. PubMed ID: 29745014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease.
    Park M; Lee SH; Lee YH; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Ahn HS; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Han DK; Baek HJ; Kook H; Hwang TJ; Lee EK; Hah JO; Lim YJ; Jung HJ; Park JE; Jang MJ; Chong SY; Oh D;
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):640-6. PubMed ID: 23380345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.